Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
potential for lower medical spend in future years
1 The telehealth option is limited to prescription renewals and is not available for new prescriptions
:max_bytes(150000):strip_icc()/HEALTH-DWL-frame-final-mounjaro-40b6d2a45d9e4841a6a77dcaecb2dd34.jpg)
Gastrointestinal symptoms are typically dose-dependent and most common during initial titration or dose escalation
In clinical studies of FDA-approved semaglutide and tirzepatide, meaningful weight loss typically became evident by 8-12 weeks
The regulatory review timeline remains Health Canada's standard 180-day process for generic applications, though complex injectable formulations may require additional review time
US$ 23.06
US$ 20.63
US$ 27.29
US$ 22.85
US$ 26.73
US$ 23.05
US$ 22.09
US$ 26.18
